FDA Drug Shortage Role Should Focus On Prevention, GPOs Suggest
Executive Summary
The Health Industry Group Purchasing Association is proposing that FDA offer a "safe haven" for manufacturers to discuss potential product discontinuations or supply disruptions
You may also be interested in...
Reimportation Should Await Track/Trace Technology, HIGPA White Paper Says
Providers interested in acquiring pharmaceuticals from outside the U.S. should first concentrate on advocacy for stronger anti-counterfeiting protections, the Health Industry Group Purchasing Association recommends in a product sourcing "white paper.
Reimportation Should Await Track/Trace Technology, HIGPA White Paper Says
Providers interested in acquiring pharmaceuticals from outside the U.S. should first concentrate on advocacy for stronger anti-counterfeiting protections, the Health Industry Group Purchasing Association recommends in a product sourcing "white paper.
FDA/Industry Drug Shortage Proposal: Early Notice On Discontinuations
An industry task force on drug shortages is considering recommending that manufacturers voluntarily notify FDA 30 to 60 days before any product is discontinued